Flok Health Raises $12.5 Million to Scale Autonomous AI Healthcare Delivery
Flok Health, a UK-based healthcare company, has closed a $12.5 million Series A funding round led by AlbionVC. Mercia Ventures joined the round, alongside existing investors Eka Ventures and Form Ventures.
The company operates an AI for Healthcare platform designed to deliver clinical care autonomously and end-to-end directly to patients. Flok said it is the first and only system in Europe approved for this type of fully autonomous healthcare delivery.
Co-founders Finn Stevenson and Ric da Silva built the platform around a straightforward premise: billions of people need medical treatment that clinicians know how to provide, but traditional care delivery cannot scale to meet demand. The company's approach decouples labor availability from care volume and quality.
Flok has already demonstrated results through partnerships with NHS trusts. The Series A capital will fund expansion into new clinical areas and geographic markets.
The Problem and the Solution
Healthcare systems face a persistent capacity constraint. The NHS and other providers struggle to match available clinical staff with patient demand. Flok's AI Agents & Automation approach addresses this by removing the requirement for human clinicians to deliver every stage of care.
Stevenson said in a statement: "Billions of people today suffer unnecessarily from conditions we know how to treat, but where traditional delivery cannot scale to meet demand. Our AI platform is the first and only system in Europe to be approved for fully autonomous end-to-end healthcare delivery direct to patients - which finally allows us to decouple the availability of labour from the volume and quality of care."
The company said the funding reflects investor confidence in both its clinical results and the scale of the opportunity in UK healthcare.
Your membership also unlocks:
